Filtering by: “USA”
Auna SA
Mar
22

Auna SA

Auna SA (Ticker: AUNA US), a Luxembourg-headquartered company, specializes in healthcare services across Spanish-speaking regions of Latin America, including operations in Mexico, Colombia, and Peru. The company's business activities encompass managing hospitals and clinics, alongside offering prepaid healthcare plans in Peru and dental and vision plans in Mexico. By the end of 2023, Auna SA operated a network that included 15 hospitals with a total of 2,301 beds and 16 outpatient, prevention, and wellness centers. For the 12-month period ending December 31, 2023, Auna SA reported revenue of USD 1,046.1 million and a net loss of USD 57.9 million.

The company is scheduled to go public on the New York Stock Exchange during the week ending on March 22, 2024, with plans to offer 30 million shares priced between USD 13.00 and 15.00. The IPO is expected to achieve a market capitalization of USD 1,034 million, with an estimated total offer size of USD 420 million. The IPO will be managed by a consortium of financial institutions, including Morgan Stanley, J.P. Morgan, BTG Pactual, Santander, Citigroup, and HSBC.

View Event →
Reddit Inc.
Mar
21

Reddit Inc.

Reddit Inc. (Ticker: RDDT US) is a social media platform company that focuses on community-driven content, where users can submit, vote on, and discuss content. It operates globally, providing a platform for a wide range of topics from news to entertainment. Reddit will list on March 21, 2024, on the New York Stock Exchange (NYSE). The company plans to offer shares priced between $31 and $34, targeting a valuation of up to $6.5 billion. This IPO is managed by lead bankers Morgan Stanley and Goldman Sachs. The company is attempting to secure an "anchor" or "cornerstone" investor, a strategy aimed at stabilizing the offering in a challenging market environment. Reddit's existing shareholders include prominent names such as Fidelity and Tencent. Despite its influential role in internet culture and substantial sales from advertising, Reddit has yet to report a profit, with a $91 million loss recorded in 2023 and $800 million in sales primarily from advertising. Additionally, the company is exploring revenue opportunities by licensing user data to AI groups, including a deal with Google worth approximately $60 million annually​​. Read the latest IPOX® Watch on the company.

View Event →
Astera Labs Inc.
Mar
20

Astera Labs Inc.

Astera Labs Inc. (Ticker: ALAB US) is a connectivity chip and cloud infrastructure management software company based in Santa Clara, California. Astera Labs focuses on resolving connectivity bottlenecks within AI infrastructure, offering solutions to increase data and memory bandwidth and capacity for CPUs and GPUs. Astera Labs Inc. is scheduled to list on the Nasdaq on March 20, 2024. The firm plans to offer 17.8 million shares, priced between $32 to $34 each (upsized from initial $27-30 range), aiming to raise up to $673 million. Upon completion of the IPO, Astera Labs will have 150.5 million shares outstanding, valuing the company at approximately $5.1 billion at the top end of the price range. The IPO is managed by lead underwriters Morgan Stanley and JPMorgan, among a total of 12 banks involved in the transaction.
The proceeds from the offering are intended for working capital, general corporate purposes, and potentially for acquisitions. Founded in 2017, Astera Labs has not yet achieved profitability, with a net loss of $26.3 million in 2023, which was an improvement from a $58.3 million loss in 2022. The company's revenue for 2023 was $115.8 million, up from $79.9 million the previous year.

View Event →
Amer Sports Inc
Feb
1

Amer Sports Inc

Amer Sports Inc (Ticker: AS US) is a multinational sporting equipment company based in Helsinki, Finland. Amer Sports owns a diverse portfolio of companies including Atomic, Arc'teryx, Armada, Enve Composites, Peak Performance, Salomon, and Wilson.
Amer Sports Inc will list on the New York Stock Exchange. The Initial Public Offering is expected to raise USD 1.80 billion, with the offering including 100 million shares at an expected price range of USD 16.00 - 18.00 per share. The expected trading date is January 31, 2024. The offering is managed by a team of underwriters including Goldman Sachs, BofA Securities, Citigroup Inc, JP Morgan, Morgan Stanley, and UBS Investment Bank/US. Additionally, the IPO includes a greenshoe option of 15%, representing an additional 15 million shares.

View Event →
BrightSpring Health Services Inc
Jan
26

BrightSpring Health Services Inc

BrightSpring Health Services Inc. (Ticker: BTSG US) is a United States-based company operating in the healthcare services industry. Specializing in home- and community-based health services, BrightSpring Health Services focuses on delivering quality outcomes for complex populations needing specialized and/or chronic care. The company's range of services includes home health care, hospice, home care for seniors, long-term specialty care for behavioral and neuro rehabilitation populations, and pharmacy therapy management across various settings.
BrightSpring Health Services is set to go public on NASDAQ GS, with an expected trading date of January 26, 2024. The company is planning to raise USD 960 million through the sale of 53.33 million shares, with an expected price range of USD 15.00 to 18.00 per share. Additionally, there is a greenshoe option of 15%, amounting to 8 million shares. The offering is managed by a team including Goldman Sachs (Left Lead), BMO Capital Markets Corp, BofA Securities, Deutsche Bank Securities Inc, and Guggenheim Securities LLC, among others.

View Event →
CG Oncology Inc
Jan
25

CG Oncology Inc

CG Oncology Inc (Ticker: CGON US) is a biotechnology company based in the United States, focused on developing and commercializing innovative immunotherapies for urologic cancer patients, with a particular emphasis on bladder cancer. Their leading product candidate is cretostimogene grenadenorepvec, an investigational engineered oncolytic immunotherapy designed as a potential bladder-sparing therapeutic for patients with bladder cancer. However, it's important to note that cretostimogene grenadenorepvec is currently not approved by any regulatory agency, and its safety and effectiveness have not been established.


CG Oncology Inc plans to go public through an Initial Public Offering on NASDAQ GM. The IPO is set to launch on January 25, 2024. The company expects to raise USD 306 million, offering 17 million shares at an expected price range of USD 16.00 to 18.00 per share. Additionally, there is a greenshoe option of 15%, amounting to 2.55 million shares. The offering is managed by Morgan Stanley & Co Inc (Left Lead), Cantor Fitzgerald & Co, and Goldman Sachs.

View Event →
Smith Douglas Homes Corp
Jan
11

Smith Douglas Homes Corp

Smith Douglas Homes Corp (Ticker: SDHC US) is a United States-based company operating in the Building - Residential/Commercial industry. Founded in 2008, the company specializes in constructing quality homes at affordable prices. Smith Douglas Homes Corp has a strong presence in key U.S. markets, including Alabama, Georgia, North Carolina, Tennessee, and Texas.

The company is preparing for an IPO on the New York Stock Exchange, expected to occur on January 11, 2024. Smith Douglas Homes Corp aims to raise USD 161.538 million by offering 7.69 million shares at an expected price range of USD 18.00 to 21.00 per share. A greenshoe option of 15% is available, amounting to 1.15 million additional shares. The offering is being managed by JP Morgan Securities LLC (Left Lead), BofA Securities, Nomura Securities International, RBC Capital Markets, Wells Fargo Securities LLC, and Zelman Partners.

View Event →
NB Bancorp Inc
Dec
28

NB Bancorp Inc

NB Bancorp Inc (Ticker: NBBK US) is a United States-based bank holding company for Needham Bank. Needham Bank, headquartered in Needham, Massachusetts, offers a range of financial products and services and is known as the "Builder's Bank."

NB Bancorp Inc is set to list on the NASDAQ Capital Market on December 28, 2023. The company is offering 34.50 million shares at a price of USD 10.00 per share, with a total offer size of USD 345.00 million. Piper Sandler & Co is managing the offering.

NB Bancorp Inc has completed its initial public offering as part of its transition from a mutual holding company to a stock holding company. The company sold 40,997,500 shares in the offering and contributed 1,708,229 shares and USD 2.0 million in cash to the Needham Bank Charitable Foundation, Inc. Legal counsel for the company and the bank is provided by Luse Gorman, PC, while Goodwin Procter LLP acted as legal counsel to Piper Sandler & Co in the offering.

View Event →
Shimmick Corp
Nov
14

Shimmick Corp

Shimmick Corp (Ticker: SHIM US), specializing in the Building - Heavy Construction industry, is a construction firm headquartered in Irvine, California. It operates with over 2,000 employees and has regional offices in Suisun City, California, and Denver, Colorado. The company is well-established in water infrastructure and critical infrastructure solutions across the United States.

Shimmick Corp announced its Initial Public Offering on NASDAQ GM in the United States on 10/05/2023. However, the offering was downsized, pricing on 11/13/2023 at USD 7 per share, lower than the initially expected price range of USD 10.00 - 12.00. The firm is now selling 3.58M primary shares, reducing the total offer size to USD 25.03M. The offering was managed by Roth Capital Partners Inc, and the company's Market Capitalization at offer is USD 185.28M. Shimmick Corp's trade date is set for 11/14/23, and the IPO includes a greenshoe option of 15%, amounting to 536.30k shares.

View Event →
Cargo Therapeutics
Nov
10

Cargo Therapeutics

Cargo Therapeutics Inc (Ticker: CRGX US) is in a Stanford-born biotech startup, focusing on developing cell therapies for cancer. The company is scheduled to list on NASDAQ GS on November 10, 2023. Cargo Therapeutics Inc is offering 18.75 million shares within an expected price range of USD 15.00 to 17.00. The total offer size is USD 318.75 million. JP Morgan Securities, Cowen & Co, Jefferies LLC, and Truist Securities Inc manage the offering. The company plans to allocate a significant portion of the IPO proceeds to fund Phase II trials of its lead Car T-Cell therapy candidate, CRG-022, and further research and development, providing cash flow into 2025.

View Event →